Daisuke Usui
Chief Operating Officer chez REPROCELL INCORPORATED
Fortune : 176 497 $ au 31/03/2024
Profil
Daisuke Usui is currently the Chief Operating Officer & Director at ReproCELL, Inc. He is also a Director at ReproCELL USA, Inc., RC Partners, Inc., ReproCELL Europe Ltd., and MAGiQ Therapeutics KK.
Previously, he served as the Chief Executive Officer at Reinnervate Ltd.
Mr. Usui completed his undergraduate degree at the University of Tsukuba.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
REPROCELL INC.
0,19% | 31/03/2023 | 168 000 ( 0,19% ) | 176 497 $ | 31/03/2024 |
Postes actifs de Daisuke Usui
| Sociétés | Poste | Début |
|---|---|---|
| REPROCELL INCORPORATED | Chief Operating Officer | 11/11/2020 |
RC Partners, Inc.
 RC Partners, Inc. Investment ManagersFinance RC Partners, Inc. engages in the operation and management of investment funds. The company was founded on February 12, 2014 and is headquartered in Yokohama, Japan. | Director/Board Member | 01/06/2016 |
ReproCELL Europe Ltd.
 ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ReproCELL, Inc., ReproCELL Europe Ltd. is a British company that specializes in providing solutions for translating scientific discoveries into therapies. The private company is based in Glasgow, UK. The company's expertise lies in human tissue and stem cells, and they offer consultation services to researchers facing challenges in their research. David C. Bunton has been the CEO of the company since 2017. | Director/Board Member | 01/07/2016 |
ReproCELL USA, Inc.
 ReproCELL USA, Inc. Medical/Nursing ServicesHealth Services ReproCELL USA, Inc. is based in Beltsville, MD. Part of ReproCELL, Inc., ReproCELL USA, Inc. is a company that engages in iPS cell research business. | Director/Board Member | 01/09/2016 |
| MAGiQ Therapeutics KK | Director/Board Member | 01/12/2019 |
Anciens postes connus de Daisuke Usui
| Sociétés | Poste | Fin |
|---|---|---|
Reinnervate Ltd.
 Reinnervate Ltd. BiotechnologyHealth Technology Reinnervate Ltd. operates as a life sciences company that develops, manufactures, and sells products for three dimensional (3D) cell culture applications that include cancer research, drug discovery, HTS, stem cell biology, and others. It offers Alvetex, a porous polystyrene scaffold designed for 3D cell culture. The company was founded by Stefan A. Przyborski in 2002 and is headquartered in Sedgefield, the United Kingdom. | Chief Executive Officer | - |
Formation de Daisuke Usui
| University of Tsukuba | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REPROCELL INCORPORATED | Health Technology |
| Entreprise privées | 5 |
|---|---|
Reinnervate Ltd.
Reinnervate Ltd. BiotechnologyHealth Technology Reinnervate Ltd. operates as a life sciences company that develops, manufactures, and sells products for three dimensional (3D) cell culture applications that include cancer research, drug discovery, HTS, stem cell biology, and others. It offers Alvetex, a porous polystyrene scaffold designed for 3D cell culture. The company was founded by Stefan A. Przyborski in 2002 and is headquartered in Sedgefield, the United Kingdom. | Health Technology |
ReproCELL USA, Inc.
ReproCELL USA, Inc. Medical/Nursing ServicesHealth Services ReproCELL USA, Inc. is based in Beltsville, MD. Part of ReproCELL, Inc., ReproCELL USA, Inc. is a company that engages in iPS cell research business. | Health Services |
RC Partners, Inc.
RC Partners, Inc. Investment ManagersFinance RC Partners, Inc. engages in the operation and management of investment funds. The company was founded on February 12, 2014 and is headquartered in Yokohama, Japan. | Finance |
ReproCELL Europe Ltd.
ReproCELL Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ReproCELL, Inc., ReproCELL Europe Ltd. is a British company that specializes in providing solutions for translating scientific discoveries into therapies. The private company is based in Glasgow, UK. The company's expertise lies in human tissue and stem cells, and they offer consultation services to researchers facing challenges in their research. David C. Bunton has been the CEO of the company since 2017. | Commercial Services |
| MAGiQ Therapeutics KK |
